Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

Pharmacological modulation of radiation-induced oral mucosal complications.

Bockel S, Vallard A, Lévy A, François S, Bourdis M, Le Gallic C, Riccobono D, Annede P, Drouet M, Tao Y, Blanchard P, Deutsch É, Magné N, Chargari C.

Cancer Radiother. 2018 May 15. pii: S1278-3218(18)30074-X. doi: 10.1016/j.canrad.2017.11.006. [Epub ahead of print]

PMID:
29776830
2.

Primary bacterial ventriculitis in adults, an emergent diagnosis challenge: report of a meningoccal case and review of the literature.

Lesourd A, Magne N, Soares A, Lemaitre C, Taha MK, Gueit I, Wolff M, Caron F.

BMC Infect Dis. 2018 May 18;18(1):226. doi: 10.1186/s12879-018-3119-4.

3.

Biological aspects of chondrosarcoma: Leaps and hurdles.

Mery B, Espenel S, Guy JB, Rancoule C, Vallard A, Aloy MT, Rodriguez-Lafrasse C, Magné N.

Crit Rev Oncol Hematol. 2018 Jun;126:32-36. doi: 10.1016/j.critrevonc.2018.03.009. Epub 2018 Mar 22. Review.

PMID:
29759564
4.

[Oligometastatic breast cancer : therapeutic implications of a new paradigm].

Méry B, Moriceau G, Vallard A, Jacquin JP, Magné N.

Rev Med Brux. 2018;39(2):111-113. doi: 10.30637/2018.16-054. French.

PMID:
29722493
5.

[Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie].

Guillot B, Charles J, Jeudy G, Cupissol D, Dupuy A, Dutriaux C, Gangloff D, Magne N, Mirabel X, M'Sadek A, Pracht M, Sichel C, Do Outeiro G.

Ann Dermatol Venereol. 2018 Apr 24. pii: S0151-9638(18)30315-6. doi: 10.1016/j.annder.2018.03.165. [Epub ahead of print] French. No abstract available.

PMID:
29703640
6.

Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review.

Rivoirard R, Langrand-Escure J, Oriol M, Tinquaut F, Chauvin F, Rancoule C, Magné N, Bourmaud A.

Crit Rev Oncol Hematol. 2018 May;125:78-83. doi: 10.1016/j.critrevonc.2018.02.014. Epub 2018 Mar 10. Review.

PMID:
29650280
7.

Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients.

Goineau A, Campion L, d'Aillières B, Vié B, Ghesquière A, Béra G, Jaffres D, de Laroche G, Magné N, Artignan X, Chamois J, Bergerot P, Martin E, Créhange G, Deniaud-Alexandre E, Buthaud X, Belkacémi Y, Doré M, de Decker L, Supiot S.

PLoS One. 2018 Apr 9;13(4):e0194173. doi: 10.1371/journal.pone.0194173. eCollection 2018.

8.

Correction to: From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience.

Espenel S, Garcia MA, Trone JC, Guillaume E, Harris A, Rehailia-Blanchard A, He MY, Ouni S, Vallard A, Rancoule C, Mrad MB, Chauleur C, De Laroche G, Guy JB, Moreno-Acosta P, Magné N.

Radiat Oncol. 2018 Mar 23;13(1):50. doi: 10.1186/s13014-018-0999-9.

9.

Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events-a meta-analysis.

Trone JC, Ollier E, Chapelle C, Bertoletti L, Cucherat M, Mismetti P, Magné N, Laporte S.

Ann Oncol. 2018 Apr 1;29(4):803-811. doi: 10.1093/annonc/mdy035.

PMID:
29415169
10.

Radiotherapy of rectal cancer in elderly patients: Real-world data assessment in a decade.

Diao P, Langrand-Escure J, Garcia MA, Espenel S, Rehailia-Blanchard A, de Lavigerie B, Vial N, de Laroche G, Vallard A, Magné N.

Dig Liver Dis. 2018 Feb 3. pii: S1590-8658(18)30136-1. doi: 10.1016/j.dld.2018.01.122. [Epub ahead of print]

PMID:
29409780
11.

Comparison of enhancement of the vestibular perilymph between gadoterate meglumine and gadobutrol at 3-Tesla in Meniere's disease.

Eliezer M, Poillon G, Gillibert A, Horion J, Cruypeninck Y, Gerardin E, Magne N, Attyé A.

Diagn Interv Imaging. 2018 May;99(5):271-277. doi: 10.1016/j.diii.2018.01.002. Epub 2018 Feb 15.

PMID:
29398574
12.

From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience.

Espenel S, Garcia MA, Trone JC, Guillaume E, Harris A, Rehailia-Blanchard A, He MY, Ouni S, Vallard A, Rancoule C, Ben Mrad M, Chauleur C, De Laroche G, Guy JB, Moreno-Acosta P, Magné N.

Radiat Oncol. 2018 Feb 2;13(1):16. doi: 10.1186/s13014-018-0963-8. Erratum in: Radiat Oncol. 2018 Mar 23;13(1):50.

13.

A retrospective survey of the last 3 months of life in patients carrying glioblastoma: Clinical treatments and profiles.

Rivoirard R, Vallard A, Boutet C, Falk AT, Garin C, Adjabi A, Hoarau D, Forest F, Fotso MJ, Rancoule C, Magné N.

Mol Clin Oncol. 2018 Jan;8(1):115-120. doi: 10.3892/mco.2017.1479. Epub 2017 Nov 2.

14.

Evaluation of the Cell Invasion and Migration Process: A Comparison of the Video Microscope-based Scratch Wound Assay and the Boyden Chamber Assay.

Guy JB, Espenel S, Vallard A, Battiston-Montagne P, Wozny AS, Ardail D, Alphonse G, Rancoule C, Rodriguez-Lafrasse C, Magne N.

J Vis Exp. 2017 Nov 17;(129). doi: 10.3791/56337.

PMID:
29286429
15.

[Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer].

Vignot S, André T, Caux C, Bouleuc C, Evrard S, Gonçalves A, Lacroix M, Magné N, Massard C, Mazeron JJ, Orbach D, Rodrigues M, Thariat J, Wislez M, L'Allemain G, Bay JO.

Bull Cancer. 2018 Jan;105(1):6-14. doi: 10.1016/j.bulcan.2017.11.006. Review. French.

PMID:
29269176
16.

Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review.

Langrand-Escure J, Rivoirard R, Oriol M, Tinquaut F, Rancoule C, Chauvin F, Magné N, Bourmaud A.

PLoS One. 2017 Dec 7;12(12):e0185536. doi: 10.1371/journal.pone.0185536. eCollection 2017.

17.

[Towards a better use of midazolam in end of life: A survey in a department of medical oncology].

Beneton A, Vallard A, Brosse C, Poenou G, Pacaut C, Magné N, Morisson S.

Bull Cancer. 2017 Nov;104(11):929-936. doi: 10.1016/j.bulcan.2017.10.003. Epub 2017 Nov 15. French.

PMID:
29150095
18.

[Impairment of DNA damage response and cancer].

Rancoule C, Vallard A, Guy JB, Espenel S, Sauvaigo S, Rodriguez-Lafrasse C, Magné N.

Bull Cancer. 2017 Nov;104(11):962-970. doi: 10.1016/j.bulcan.2017.09.006. Epub 2017 Nov 11. Review. French.

PMID:
29132683
19.

[Biomarkers of radiation-induced DNA repair processes].

Vallard A, Rancoule C, Guy JB, Espenel S, Sauvaigo S, Rodriguez-Lafrasse C, Magné N.

Bull Cancer. 2017 Nov;104(11):981-987. doi: 10.1016/j.bulcan.2017.09.004. Epub 2017 Nov 10. Review. French.

PMID:
29132682
20.

Healing touch in radiation therapy: is the benefit tangible?

Guy JB, Bard-Reboul S, Trone JC, Vallard A, Espenel S, Langrand-Escure J, Hamrouni A, Mrad MB, Morisson S, Michaud P, Magné N, Rancoule C.

Oncotarget. 2017 Aug 30;8(46):81485-81491. doi: 10.18632/oncotarget.20594. eCollection 2017 Oct 6.

21.

[The 150th anniversary of Marie Curie].

Mazeron JJ, Magné N, Thariat J.

Bull Cancer. 2017 Nov;104(11):912-913. doi: 10.1016/j.bulcan.2017.10.001. Epub 2017 Nov 3. French. No abstract available.

PMID:
29108642
22.

Predictive Factors of Headache Resolution After Chiari Type 1 Malformation Surgery.

Grangeon L, Puy L, Gilard V, Hebant B, Langlois O, Derrey S, Gerardin E, Maltete D, Guegan-Massardier E, Magne N.

World Neurosurg. 2018 Feb;110:e60-e66. doi: 10.1016/j.wneu.2017.10.070. Epub 2017 Oct 21.

PMID:
29066319
23.

Navigating the highlights of phase III trials: a watchful eye on evidence-based radiotherapy.

Trone JC, Espenel S, Rehailia-Blanchard A, Guillaume E, Vial N, Rancoule C, Rodriguez-Lafrasse C, Ben Mrad M, El Meddeb Hamrouni A, Ollier E, Chargari C, Deutsch E, Vallard A, Magné N.

Ann Oncol. 2017 Nov 1;28(11):2691-2697. doi: 10.1093/annonc/mdx347. Review.

PMID:
29045516
24.

Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol.

Bernichon E, Vallard A, Wang Q, Attignon V, Pissaloux D, Bachelot T, Heudel PE, Ray-Coquard I, Bonnet E, de la Fouchardière A, Faure C, Chopin N, Beurrier F, Racadot S, Sunyach MP, Rancoule C, Perol D, Corset V, Agrapart V, Tinquaut F, Blay JY, Magné N, Trédan O.

Ann Oncol. 2017 Nov 1;28(11):2773-2779. doi: 10.1093/annonc/mdx488.

PMID:
28945826
25.

Dual "mAb" HER family blockade in head and neck cancer human cell lines combined with photon therapy.

Guy JB, Méry B, Ollier E, Espenel S, Vallard A, Wozny AS, Simonet S, Lauret A, Battiston-Montagne P, Ardail D, Alphonse G, Rancoule C, Rodriguez-Lafrasse C, Magné N.

Sci Rep. 2017 Sep 22;7(1):12207. doi: 10.1038/s41598-017-12367-7.

26.

Gadolinium-based nanoparticles as sensitizing agents to carbon ions in head and neck tumor cells.

Wozny AS, Aloy MT, Alphonse G, Magné N, Janier M, Tillement O, Lux F, Beuve M, Rodriguez-Lafrasse C.

Nanomedicine. 2017 Nov;13(8):2655-2660. doi: 10.1016/j.nano.2017.07.015. Epub 2017 Aug 2.

PMID:
28779947
27.

Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma.

Moreno-Acosta P, Vallard A, Carrillo S, Gamboa O, Romero-Rojas A, Molano M, Acosta J, Mayorga D, Rancoule C, Garcia MA, Cotes Mestre M, Magné N.

Radiat Oncol. 2017 Jul 17;12(1):120. doi: 10.1186/s13014-017-0856-2.

28.

Radiotherapy among nonagenarians with anal or rectal carcinoma: should we avoid or adapt treatment?

Vallard A, Rancoule C, Guy JB, Assouline A, Falk AT, Auberdiac P, Langrand-Escure J, Chargari C, Magné N.

Chin J Cancer. 2017 Jul 14;36(1):56. doi: 10.1186/s40880-017-0224-5. No abstract available.

29.

Brain metastases from non-small cell lung carcinoma: Changing concepts for improving patients' outcome.

Rancoule C, Vallard A, Guy JB, Espenel S, Diao P, Chargari C, Magné N.

Crit Rev Oncol Hematol. 2017 Aug;116:32-37. doi: 10.1016/j.critrevonc.2017.05.007. Epub 2017 May 20. Review.

PMID:
28693798
30.

[Medical prevention and treatment of radiation-induced pulmonary complications].

Vallard A, Rancoule C, Le Floch H, Guy JB, Espenel S, Le Péchoux C, Deutsch É, Magné N, Chargari C.

Cancer Radiother. 2017 Aug;21(5):411-423. doi: 10.1016/j.canrad.2017.03.004. Epub 2017 Jun 5. Review. French.

PMID:
28596060
31.

Comparison of electromagnetic neuronavigation system and free-hand method for ventricular catheter placement in internal shunt.

Gilard V, Magne N, Gerardin E, Curey S, Pelletier V, Hannequin P, Derrey S.

Clin Neurol Neurosurg. 2017 Jul;158:93-97. doi: 10.1016/j.clineuro.2017.05.007. Epub 2017 May 8.

PMID:
28500927
32.

Management and outcome of cerebral venous thrombosis after head trauma: A case series.

Grangeon L, Gilard V, Ozkul-Wermester O, Lefaucheur R, Curey S, Gerardin E, Derrey S, Maltete D, Magne N, Triquenot A.

Rev Neurol (Paris). 2017 Jun;173(6):411-417. doi: 10.1016/j.neurol.2017.03.025. Epub 2017 May 8.

PMID:
28495232
33.

[Immunotherapy: Activation of a system not a pathway].

Bernichon E, Rancoule C, Vallard A, Langrand-Escure J, Mery B, Guy JB, Magné N.

Bull Cancer. 2017 May;104(5):462-475. doi: 10.1016/j.bulcan.2017.03.004. Epub 2017 May 3. Review. French.

PMID:
28477871
34.

In Vitro Cell Death Determination for Drug Discovery: A Landscape Review of Real Issues.

Méry B, Guy JB, Vallard A, Espenel S, Ardail D, Rodriguez-Lafrasse C, Rancoule C, Magné N.

J Cell Death. 2017 Feb 24;10:1179670717691251. doi: 10.1177/1179670717691251. eCollection 2017. Review.

35.

Long-Lasting Cerebral Vasospasm, Microthrombosis, Apoptosis and Paravascular Alterations Associated with Neurological Deficits in a Mouse Model of Subarachnoid Hemorrhage.

El Amki M, Dubois M, Lefevre-Scelles A, Magne N, Roussel M, Clavier T, Guichet PO, Gérardin E, Compère V, Castel H.

Mol Neurobiol. 2018 Apr;55(4):2763-2779. doi: 10.1007/s12035-017-0514-6. Epub 2017 Apr 28.

PMID:
28455691
36.

Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry.

Guy JB, Bertoletti L, Magné N, Rancoule C, Mahé I, Font C, Sanz O, Martín-Antorán JM, Pace F, Vela JR, Monreal M; RIETE investigators.

Crit Rev Oncol Hematol. 2017 May;113:83-89. doi: 10.1016/j.critrevonc.2017.03.006. Epub 2017 Mar 9.

PMID:
28427527
37.

The world of targeted therapies in kidney cancers: pitfalls, tips and tricks.

Vallard A, Trone JC, Langrand-Escure J, Espenel S, Guy JB, Rancoule C, Xia Y, El Meddeb Hamrouni A, Ben Mrad M, Magné N.

Onco Targets Ther. 2017 Mar 3;10:1375-1380. doi: 10.2147/OTT.S127919. eCollection 2017.

38.

Differential pattern of HIF-1α expression in HNSCC cancer stem cells after carbon ion or photon irradiation: one molecular explanation of the oxygen effect.

Wozny AS, Lauret A, Battiston-Montagne P, Guy JB, Beuve M, Cunha M, Saintigny Y, Blond E, Magne N, Lalle P, Ardail D, Alphonse G, Rodriguez-Lafrasse C.

Br J Cancer. 2017 May 9;116(10):1340-1349. doi: 10.1038/bjc.2017.100. Epub 2017 Apr 13.

39.

Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index.

Rancoule C, Espenel S, Trone JC, Langrand-Escure J, Vallard A, Rehailia-Blanchard A, El Meddeb Hamrouni A, Xia Y, Guy JB, Ben-Mrad M, Magné N.

Oncotarget. 2017 Jun 27;8(26):43543-43554. doi: 10.18632/oncotarget.16672. Review.

40.

Atrial fibrillation in cancer patients: Hindsight, insight and foresight.

Mery B, Guichard JB, Guy JB, Vallard A, Barthelemy JC, Da Costa A, Magné N, Bertoletti L.

Int J Cardiol. 2017 Aug 1;240:196-202. doi: 10.1016/j.ijcard.2017.03.132. Epub 2017 Apr 6. Review.

PMID:
28390744
41.

[Atypical presentation of a breast cancer pituitary metastasis].

Langrand-Escure J, Vallard A, Suchaud JP, Diao P, Magné N.

Rev Med Liege. 2016 Jul;71(7-8):332-335. French.

42.

HPV-16 variants' impact on uterine cervical cancer response to radiotherapy: A descriptive pilot study.

Moreno-Acosta P, Vallard A, Molano M, Huertas A, Gamboa Ó, Cotes M, Romero-Rojas A, Rancoule C, Magné N.

Cancer Radiother. 2017 Apr;21(2):104-108. doi: 10.1016/j.canrad.2016.09.018. Epub 2017 Mar 18.

PMID:
28325620
43.

Quality of reporting in oncology studies: A systematic analysis of literature reviews and prospects.

Rivoirard R, Bourmaud A, Oriol M, Tinquaut F, Méry B, Langrand-Escure J, Vallard A, Fournel P, Magné N, Chauvin F.

Crit Rev Oncol Hematol. 2017 Apr;112:179-189. doi: 10.1016/j.critrevonc.2017.02.012. Epub 2017 Feb 24. Review.

PMID:
28325258
44.

Growth of giant intracranial aneurysms: An aneurysmal wall disorder?

Ferracci FX, Gilard V, Cebula H, Magne N, Lejeune JP, Langlois O, Proust F.

Neurochirurgie. 2017 Mar;63(1):6-12. doi: 10.1016/j.neuchi.2017.01.001. Epub 2017 Mar 8.

PMID:
28284448
45.

Bilateral Breast Cancer After Prophylactic Bilateral Pulmonary Irradiation.

El Meddeb HA, Chehata JM, Kanoun S, Rancoule C, Guy JB, Magne N, Bouaouina N.

Gulf J Oncolog. 2017 Jan;1(23):63-66.

PMID:
28272005
46.

[Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].

Espenel S, Garcia MA, Guy JB, Vallard A, Ben Mrad M, Langrand-Escure J, El Meddeb Hamrouni A, Trone JC, Xia Y, Rancoule C, Magné N.

Cancer Radiother. 2017 Feb;21(1):77-83. doi: 10.1016/j.canrad.2016.08.130. Epub 2017 Feb 8. French.

PMID:
28189351
47.

Preclinical models in HNSCC: A comprehensive review.

Méry B, Rancoule C, Guy JB, Espenel S, Wozny AS, Battiston-Montagne P, Ardail D, Beuve M, Alphonse G, Rodriguez-Lafrasse C, Magné N.

Oral Oncol. 2017 Feb;65:51-56. doi: 10.1016/j.oraloncology.2016.12.010. Epub 2016 Dec 28. Review.

PMID:
28109468
48.

Melanoma: Last call for radiotherapy.

Espenel S, Vallard A, Rancoule C, Garcia MA, Guy JB, Chargari C, Deutsch E, Magné N.

Crit Rev Oncol Hematol. 2017 Feb;110:13-19. doi: 10.1016/j.critrevonc.2016.12.003. Epub 2016 Dec 10. Review.

PMID:
28109401
49.

Corrigendum: Influence of Dose Rate on the Cellular Response to Low- and High-LET Radiations.

Wozny AS, Alphonse G, Battiston-Montagne P, Simonet S, Poncet D, Testa E, Guy JB, Rancoule C, Magné N, Beuve M, Rodriguez-Lafrasse C.

Front Oncol. 2017 Jan 19;6:271. doi: 10.3389/fonc.2016.00271. eCollection 2016.

50.

Novel predictive biomarkers for cervical cancer prognosis.

Moreno-Acosta P, Carrillo S, Gamboa O, Romero-Rojas A, Acosta J, Molano M, Balart-Serra J, Cotes M, Rancoule C, Magné N.

Mol Clin Oncol. 2016 Dec;5(6):792-796. doi: 10.3892/mco.2016.1055. Epub 2016 Oct 19.

Supplemental Content

Support Center